Mc Kinley Carter Wealth Services, Inc. Bristol Myers Squibb CO Transaction History

Mc Kinley Carter Wealth Services, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$68.48 - $81.09 $24,036 - $28,462	-351 Reduced 10.1%	3,123 $224,000
Q3 2022 Oct 24, 2022	BUY	$0.13 - $76.84 $38 - $22,744	296 Added 9.31%	3,474 $247,000
Q2 2022 Jul 15, 2022	SELL	$72.62 - $79.98 $72 - $79	-1 Reduced 0.03%	3,178 $245,000
Q1 2022 Apr 27, 2022	SELL	$61.48 - $73.72 $12,849 - $15,407	-209 Reduced 6.17%	3,179 $232,000
Q4 2021 Feb 07, 2022	SELL	$53.63 - $62.52 $146,409 - $170,679	-2,730 Reduced 44.62%	3,388 $211,000
Q3 2021 Nov 03, 2021	SELL	$59.17 - $69.31 $15,857 - $18,575	-268 Reduced 4.2%	6,118 $362,000
Q2 2021 Aug 12, 2021	SELL	$61.91 - $67.42 $12,258 - $13,349	-198 Reduced 3.01%	6,386 $427,000
Q1 2021 Apr 30, 2021	BUY	$59.34 - $66.74 $4,865 - $5,472	82 Added 1.26%	6,584 $416,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $375,425 - $425,425	6,502 New	6,502 $403,000
Q2 2018 Dec 07, 2018	SELL	$50.53 - $62.98 $12,632 - $15,745	-250 Closed	0 $0
Q1 2018 May 17, 2018	BUY	$59.92 - $68.98 $14,980 - $17,245	250 New	250 $16,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Mc Kinley Carter Wealth Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Mc Kinley Carter Wealth Services, Inc. with notifications on news.